DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Infertility (Testing & Treatment) Market Forecast 2017-2025" report to their offering.
The Global Infertility testing and treatment market generated a revenue of $19389.8 million in 2016 and is anticipated to contribute $33665.86 million by 2025, growing at a CAGR of 6.35%.
Various reasons for growth of the fertilization market are increasing infertility across the world, delayed pregnancies, growing social acceptance of fertilization techniques, improving healthcare infrastructure and more awareness.
WHO estimated that almost 25% couples in developing countries are infertile. There is a growing rate of infertility all over the globe. Reasons for infertility are increasing late marriages leading to higher maternal age, gynecological issues, growing incidences of obesity and addiction to alcohol, smoking and tobacco.
The major market players for fertilization are Vitrolife AB, EMD Serono Inc., Irvine Scientific, Cooper Surgical Inc., Cook Medical Inc., Thermo Fisher Scientific Inc., Genea Biomedx, Boston IVF, Progyny Inc. and Ovascience.
Companies are forming alliances and are going for mergers and acquisitions to strengthen their market position. Organizations are investing in research and development to come up with novel and innovative products that will capture new market share.
Infertility Causes & Markey Dynamics
Male And Female Infertility
Drivers And Impact
- Rise In Infertility
- Fertility Tourism
- Surrogacy Also Responsible For Fertility Tourism
- Technological Advancement In Healthcare Domain
- Increase In Success Rate Of Treatments
- Increasing Acceptance Of Donor Eggs By Consumers
Restrains And Impact
- Expensive Procedure
- Legal Issues
- Global Requirement For Low Cost Instruments And Drugs In Ivf
- Ivf An Attractive Sector For Investment For Private Equity Investors
- Low Acceptance Of Infertility Treatment Amongst Men
- Multiple Births And Birth Defects
- Andrology Solutions
- Auxilium Solutions
- Ferring Pharmaceuticals
- Irvene Scientific
- Merck Serono
For more information about this report visit http://www.researchandmarkets.com/research/t429tj/global